Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial

Area of Science:

• Gynecology and Obstetrics
• Surgical Oncology
• Pharmacology

Background:

• Endometriosis is a chronic condition requiring surgical intervention.
• Conservative surgery aims to preserve reproductive organs but recurrence is common.
• Adjuvant therapies are explored to improve surgical outcomes.

Purpose of the Study:

• To compare outcomes of conservative endometriosis surgery with and without pentoxifylline.
• To evaluate pentoxifylline's efficacy in preventing endometriosis recurrence post-surgery.

Main Methods:

• A parallel-group, randomized, controlled trial was conducted.
• Women undergoing laparoscopic conservative endometriosis surgery were randomized.
• Patients received either pentoxifylline or a placebo post-operatively.

Main Results:

• No significant differences in baseline characteristics between groups.
• Both groups showed significant improvement in Visual Analog Scale (VAS) pain scores post-surgery.
• Pentoxifylline group demonstrated significantly better VAS scores at 2 and 3 months post-operatively.

Conclusions:

• Pentoxifylline use post-conservative endometriosis surgery improved pain scores at 2 and 3 months.
• Longer-term pentoxifylline treatment may enhance outcomes after endometriosis surgery.